Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

KYMR

Kymera Therapeutics (KYMR)

Kymera Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:KYMR
DateTimeSourceHeadlineSymbolCompany
05/20/20222:45PMTipRanksBrookline Capital Markets Maintains a Buy Rating on Kymera Therapeutics (KYMR)NASDAQ:KYMRKymera Therapeutics Inc
05/20/20227:30AMGlobeNewswire Inc.Kymera Therapeutics Presented Preclinical Data Showcasing Impact of IRAK4 Degrader KT-474 on Immune and Skin Cells at the Society for Investigative Dermatology Annual MeetingNASDAQ:KYMRKymera Therapeutics Inc
05/09/20227:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KYMRKymera Therapeutics Inc
05/08/202210:21PMTipRanksStifel Nicolaus Remains a Buy on Kymera Therapeutics (KYMR)NASDAQ:KYMRKymera Therapeutics Inc
05/05/20228:00AMGlobeNewswire Inc.Kymera Therapeutics to Share Novel Preclinical Findings Reinforcing the Advantage of IRAK4 Degraders over Kinase Inhibitors as well as First STAT3 Degrader Results in a Preclinical Model of Th17 InflammationNASDAQ:KYMRKymera Therapeutics Inc
05/04/20226:26AMTipRanksH.C. Wainwright Thinks Kymera Therapeutics’ Stock is Going to RecoverNASDAQ:KYMRKymera Therapeutics Inc
05/04/20226:06AMTipRanksBerenberg Bank Thinks Kymera Therapeutics’ Stock is Going to RecoverNASDAQ:KYMRKymera Therapeutics Inc
05/03/20227:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KYMRKymera Therapeutics Inc
05/03/20227:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KYMRKymera Therapeutics Inc
05/03/202211:15AMTipRanksAnalysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD) and Kymera Therapeutics (KYMR)NASDAQ:KYMRKymera Therapeutics Inc
05/03/20227:17AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:KYMRKymera Therapeutics Inc
05/03/20227:11AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KYMRKymera Therapeutics Inc
05/03/20227:00AMGlobeNewswire Inc.Kymera Therapeutics Announces First Quarter 2022 Financial Results and Provides a Business UpdateNASDAQ:KYMRKymera Therapeutics Inc
04/29/20224:12PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:KYMRKymera Therapeutics Inc
04/19/20228:00AMGlobeNewswire Inc.Kymera Therapeutics to Report First Quarter 2022 Results and Announces Participation at Upcoming Investor ConferencesNASDAQ:KYMRKymera Therapeutics Inc
04/11/20224:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KYMRKymera Therapeutics Inc
04/11/20226:16AMTipRanksH.C. Wainwright Thinks Kymera Therapeutics’ Stock is Going to RecoverNASDAQ:KYMRKymera Therapeutics Inc
04/09/202211:55AMTipRanksBrookline Capital Markets Thinks Kymera Therapeutics’ Stock is Going to RecoverNASDAQ:KYMRKymera Therapeutics Inc
04/08/20221:02PMGlobeNewswire Inc.Kymera Therapeutics Presents Preclinical Data Highlighting Biological Superiority of MDM2 Degradation over Inhibition and Shares Profile of Clinical Candidate KT-253 at the American Association for Cancer Research (AACR) Annual Meeting 2022NASDAQ:KYMRKymera Therapeutics Inc
03/03/20224:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KYMRKymera Therapeutics Inc
03/03/20224:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KYMRKymera Therapeutics Inc
03/03/20224:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KYMRKymera Therapeutics Inc
03/03/20224:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KYMRKymera Therapeutics Inc
03/02/202211:47AMTipRanksMorgan Stanley Sticks to Their Hold Rating for Kymera Therapeutics (KYMR)NASDAQ:KYMRKymera Therapeutics Inc
03/02/20227:00AMGlobeNewswire Inc.Kymera Therapeutics to Participate in Upcoming March Investor ConferencesNASDAQ:KYMRKymera Therapeutics Inc
02/24/20227:32AMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:KYMRKymera Therapeutics Inc
02/24/20227:18AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:KYMRKymera Therapeutics Inc
02/24/20227:00AMGlobeNewswire Inc.Kymera Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides a Business UpdateNASDAQ:KYMRKymera Therapeutics Inc
02/14/20225:40PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:KYMRKymera Therapeutics Inc
02/14/20222:42PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:KYMRKymera Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:KYMR